Antibiotic-Induced Genetic Variation: How It Arises and How It Can Be Prevented

Annual Review of Microbiology

Volumn 72, Issue , 2018, Pages 209-230

  Blázquez, Jesús ^a,b,c   Rodríguez Beltrán, Jerónimo ^d   Matic, Ivan ^e  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^e INSERM   (France)

Author keywords

antibiotic resistance; evolvability; genetic instability; mutagenesis; mutation rates; ROS; SOS

Indexed keywords

ANTIBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; ANTIINFECTIVE AGENT;

AEROBIC METABOLISM; ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL MUTATION; GENETIC RECOMBINATION; GENETIC VARIATION; GENOMIC INSTABILITY; HORIZONTAL GENE TRANSFER; MUTAGENESIS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; REGULON; REVIEW; SOS RESPONSE (GENETICS); STRESS; ADAPTATION; BACTERIUM; DRUG EFFECT; GENETIC SELECTION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGICAL STRESS;

ADAPTATION, BIOLOGICAL; ANTI-BACTERIAL AGENTS; BACTERIA; GENETIC VARIATION; GENOMIC INSTABILITY; MUTATION; REACTIVE OXYGEN SPECIES; RECOMBINATION, GENETIC; SELECTION, GENETIC; STRESS, PHYSIOLOGICAL;

EID: 85053129297     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-090817-062139     Document Type: Review

References (163)

1. Aarestrup FM. 2005. Veterinary drug usage and antimicrobial resistance in bacteria of animal origin. Basic Clin. Pharmacol. Toxicol. 96:271-81
2. Al Mamun AA, Gautam S, Humayun MZ. 2006. Hypermutagenesis in mutA cells is mediated by mistranslational corruption of polymerase, and is accompanied by replication fork collapse. Mol. Microbiol. 62:1752-63
3. Alam MK, Alhhazmi A, DeCoteau JF, Luo Y, Geyer CR. 2016. RecA inhibitors potentiate antibiotic activity and block evolution of antibiotic resistance. Cell Chem. Biol. 23:381-91
4. Amabile-Cuevas CF, Heinemann JA. 2004. Shooting the messenger of antibiotic resistance: plasmid elimination as a potential counter-evolutionary tactic. Drug Discov. Today 9:465-67
5. Andersson DI, Hughes D. 2014. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12:465-78
6. Appelbaum PC. 2012. 2012 and beyond: potential for the start of a second pre-antibiotic era J. Antimicrob. Chemother. 67:2062-68
7. Aranda J, Lopez M, Leiva E, Magan A, Adler B, et al. 2014. Role of Acinetobacter baumannii UmuD homologs in antibiotic resistance acquired through DNA damage-induced mutagenesis. Antimicrob. Agents Chemother. 58:1771-73
8. Arriaga-Alba M, Rivera-Sanchez R, Parra-Cervantes G, Barro-Moreno F, Flores-Paz R, Garcia-Jimenez E. 2000. Antimutagenesis of-carotene to mutations induced by quinolone on Salmonella typhimurium. Arch. Med. Res. 31:156-61
9. Baharoglu Z, Babosan A, MazelD. 2014. Identification of genes involved in low aminoglycoside-induced SOS response in Vibrio cholerae: A role for transcription stalling and Mfd helicase. Nucleic Acids Res. 42:2366-79
10. Baharoglu Z, Krin E, Mazel D. 2013. RpoS plays a central role in the SOS induction by sub-lethal aminoglycoside concentrations in Vibrio cholerae. PLOS Genet. 9(4):e1003421. https://doi. org/10. 1371/ journal. pgen. 1003421
11. Baharoglu Z, Mazel D. 2011. Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: A route towards multiresistance. Antimicrob. Agents Chemother. 55:2438-41
12. Baquero F. 2001. Low-level antibacterial resistance: A gateway to clinical resistance. Drug Resist. Updates 4:93-105
13. Baquero F, Coque TM, de la Cruz F. 2011. Ecology and evolution as targets: The need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob. Agents Chemother. 55:3649-60
14. Baquero F, Lanza VF, Canton R, Coque TM. 2015. Public health evolutionary biology of antimicrobial resistance: priorities for intervention. Evol. Appl. 8:223-39
15. Baquero F, NegriMC. 1997. Selective compartments for resistantmicroorganisms in antibiotic gradients. BioEssays 19:731-36
16. Barbe J, Villaverde A, Guerrero R. 1983. Evolution of cellular ATP concentration after UV-mediated induction of SOS system in Escherichia coli. Biochem. Biophys. Res. Commun. 117:556-61
17. Battesti A, Majdalani N, Gottesman S. 2011. The RpoS-mediated general stress response in Escherichia coli. Annu. Rev. Microbiol. 65:189-213
18. Belenky P, Ye JD, Porter CB, Cohen NR, Lobritz MA, et al. 2015. Bactericidal antibiotics induce toxic metabolic perturbations that lead to cellular damage. Cell Rep. 13:968-80
19. Bellio P, Brisdelli F, Perilli M, Sabatini A, Bottoni C, et al. 2014. Curcumin inhibits the SOS response induced by levofloxacin in Escherichia coli. Phytomedicine 21:430-34
20. Bellio P, Di Pietro L, ManciniA, Piovano M, Nicoletti M, et al. 2017. SOSresponse in bacteria: inhibitory activity of lichen secondary metabolites against Escherichia coli RecA protein. Phytomedicine 29:11-18
21. Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G, et al. 2013. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLOS Genet. 9:e1003144
22. Blázquez J. 2003. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin. Infect. Dis. 37:1201-9
23. BoshoffHI, Reed MB, Barry CE 3rd, Mizrahi V. 2003. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113:183-93
24. Bunnell BE, Escobar JF, Bair KL, Sutton MD, Crane JK. 2017. Zinc blocks SOS-induced antibiotic resistance via inhibition of RecA in Escherichia coli. PLOS ONE 12:e0178303
25. Cabello FC. 2006. Heavy use of prophylactic antibiotics in aquaculture: A growing problem for human and animal health and for the environment. Environ. Microbiol. 8:1137-44
26. Cabezon E, de la Cruz F, Arechaga I. 2017. Conjugation inhibitors and their potential use to prevent dissemination of antibiotic resistance genes in bacteria. Front. Microbiol. 8:2329
27. Castaneda-Garcia A, Prieto AI, Rodriguez-Beltran J, AlonsoN, CantillonD, et al. 2017. A non-canonical mismatch repair pathway in prokaryotes. Nat. Commun. 8:14246
28. Chiang SM, Schellhorn HE. 2010. Evolution of the RpoS regulon: origin of RpoS and the conservation of RpoS-dependent regulation in bacteria. J. Mol. Evol. 70:557-71
29. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Hoiby N. 2010. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weakmutators with heterogeneous genetic backgrounds emerge in mucA and/or lasRmutants. Microbiology 156:1108-19
30. Cirz RT, Chin JK, Andes DR, de Crecy-Lagard V, Craig WA, Romesberg FE. 2005. Inhibition of mutation and combating the evolution of antibiotic resistance. PLOS Biol. 3:e176
31. Cirz RT, Romesberg FE. 2007. Controllingmutation: intervening in evolution as a therapeutic strategy. Crit. Rev. Biochem. Mol. Biol. 42:341-54
32. Cline DJ, Holt SL, Singleton SF. 2007. Inhibition of Escherichia coli RecA by rationally redesigned N-terminal helix. Org. Biomol. Chem. 5:1525-28
33. Couce A, Blázquez J. 2009. Side effects of antibiotics on genetic variability. FEMS Microbiol. Rev. 33:531-38
34. Cox EC, Gibson TC. 1974. Selection for high mutation rates in chemostats. Genetics 77:169-84
35. Cox MM. 2007. Regulation of bacterial RecA protein function. Crit. Rev. Biochem. Mol. Biol. 42:41-63
36. Crane JK, Broome JE, Reddinger RM, Werth BB. 2014. Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria. BMC Microbiol. 14:145
37. Culyba MJ, Mo CY, Kohli RM. 2015. Targets for combating the evolution of acquired antibiotic resistance. Biochemistry 54:3573-82
38. Dahan-Grobgeld E, Livneh Z, Maretzek AF, Polak-Charcon S, Eichenbaum Z, Degani H. 1998. Reversible induction of ATP synthesis by DNA damage and repair in Escherichia coli: in vivo NMR studies. J. Biol. Chem. 273:30232-38
39. Dapa T, Fleurier S, Bredeche MF, Matic I. 2017. The SOS and RpoS regulons contribute to bacterial cell robustness to genotoxic stress by synergistically regulatingDNApolymerase pol II. Genetics 206:1349-60
40. Davies J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science 264:375-82
41. Davies J, Spiegelman GB, Yim G. 2006. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9:445-53
42. Denamur E, Matic I. 2006. Evolution of mutation rates in bacteria. Mol. Microbiol. 60:820-27
43. Denamur E, Tenaillon O, Deschamps C, Skurnik D, Ronco E, et al. 2005. Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli. Genetics 171:825-27
44. Didelot X, Maiden MC. 2010. Impact of recombination on bacterial evolution. TrendsMicrobiol. 18:315-22
45. Didier JP, Villet R, Huggler E, Lew DP, Hooper DC, et al. 2011. Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance. Antimicrob. Agents Chemother. 55:1946-52
46. Dorr T, Lewis K, Vulic M. 2009. SOS response induces persistence to fluoroquinolones in Escherichia coli. PLOS Genet. 5:e1000760
47. Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, et al. 2014. Antibiotics induce redoxrelated physiological alterations as part of their lethality. PNAS 111:E2100-9
48. Erill I, Campoy S, Barbe J. 2007. Aeons of distress: An evolutionary perspective on the bacterial SOS response. FEMS Microbiol. Rev. 31:637-56
49. Fornelos N, Browning DF, Butala M. 2016. The use and abuse of LexA by mobile genetic elements. Trends Microbiol. 24:391-401
50. Foster PL. 2007. Stress-induced mutagenesis in bacteria. Crit. Rev. Biochem. Mol. Biol. 42:373-97
51. Foti JJ, Devadoss B, Winkler JA, Collins JJ, Walker GC. 2012. Oxidation of the guanine nucleotide pool underlies cell death by bactericidal antibiotics. Science 336:315-19
52. Frenoy A, Bonhoeffer S. 2018. Death and population dynamics affect mutation rate estimates and evolvability under stress in bacteria. PLOS Biol. 16(5):e2005056
53. Frisch RL, Su Y, Thornton PC, Gibson JL, Rosenberg SM, Hastings PJ. 2010. SeparateDNAPol II-and Pol IV-dependent pathways of stress-induced mutation during double-strand-break repair in Escherichia coli are controlled by RpoS. J. Bacteriol. 192:4694-700
54. Fung-Tomc J, Kolek B, Bonner DP. 1993. Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1289-96
55. Gibson TC, Scheppe ML, Cox EC. 1970. Fitness of an Escherichia coli mutator gene. Science 169:686-88
56. Gillespie SH, Basu S, Dickens AL, O'Sullivan DM, McHugh TD. 2005. Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates. J. Antimicrob. Chemother. 56:344-48
57. Giroux X, Su W, Bredeche M, Matic I. 2017. MaladaptiveDNArepair activity is the ultimate contributor to the death of trimethoprim-treated cells under aerobic and anaerobic conditions. PNAS 114:11512-17
58. Goerke C, Koller J, Wolz C. 2006. Ciprofloxacin and trimethoprim cause phage induction and virulence modulation in Staphylococcus aureus. Antimicrob. Agents Chemother. 50:171-77
59. Goh EB, Yim G, Tsui W, McClure J, Surette MG, Davies J. 2002. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. PNAS 99:17025-30
60. Goneau LW, HannanTJ, MacPhee RA, Schwartz DJ, Macklaim JM, et al. 2015. Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity. mBio 6:e00356-15
61. Goodman MF. 2014. The discovery of error-prone DNA polymerase V and its unique regulation by RecA and ATP. J. Biol. Chem. 289:26772-82
62. Goswami M, Mangoli SH, Jawali N. 2006. Involvement of reactive oxygen species in the action of ciprofloxacin against Escherichia coli. Antimicrob. Agents Chemother. 50:949-54
63. Goulas A, Haudin CS, Bergheaud V, Dumeny V, Ferhi S, et al. 2016. A new extraction method to assess the environmental availability of ciprofloxacin in agricultural soils amended with exogenous organic matter. Chemosphere 165:460-69
64. Guerin E, Cambray G, Sanchez-Alberola N, Campoy S, Erill I, et al. 2009. The SOS response controls integron recombination. Science 324:1034
65. Gullberg E, Cao S, Berg OG, Ilback C, Sandegren L, et al. 2011. Selection of resistant bacteria at very low antibiotic concentrations. PLOS Pathog. 7:e1002158
66. Gutierrez A, Laureti L, Crussard S, Abida H, Rodrguez-Rojas A, et al. 2013.-Lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication fidelity. Nat. Commun. 4:1610
67. Hastings PJ, Rosenberg SM, Slack A. 2004. Antibiotic-induced lateral transfer of antibiotic resistance. Trends Microbiol. 12:401-4
68. Henderson-Begg SK, Livermore DM, Hall LM. 2006. Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J. Antimicrob. Chemother. 57:849-54
69. HisamaM, Matsuda S, Shibayama H, IwakiM. 2008. Antimutagenic activity of a novel ascorbic derivative, disodium isostearyl 2-O-L-ascorbyl phosphate. Yakugaku Zasshi 128:933-40
70. Hisama M, Matsuda S, Tanaka T, Shibayama H, Nomura M, IwakiM. 2008. Suppression of mutagensinduced SOS response by phytoncide solution using Salmonella typhimurium TA1535/pSK1002 umu test. J. Oleo Sci. 57:381-90
71. Hocquet D, Bertrand X. 2014. Metronidazole increases the emergence of ciprofloxacin-and amikacinresistant Pseudomonas aeruginosa by inducing the SOS response. J. Antimicrob. Chemother. 69:852-54
72. Hocquet D, Llanes C, Thouverez M, Kulasekara HD, Bertrand X, et al. 2012. Evidence for induction of integron-based antibiotic resistance by the SOS response in a clinical setting. PLOS Pathog. 8:e1002778
73. Holmes AH, MooreLS, Sundsfjord A, SteinbakkM, Regmi S, et al. 2016. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387:176-87
74. Huerta-Uribe A, Marjenberg ZR, Yamaguchi N, Fitzgerald S, Connolly JP, et al. 2016. Identification and characterization of novel compounds blocking Shiga toxin expression in Escherichia coli O157:H7. Front. Microbiol. 7:1930
75. Hughes D, Andersson DI. 2012. Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr. Opin. Microbiol. 15:555-60
76. Hughes D, Andersson DI. 2017. Evolutionary trajectories to antibiotic resistance. Annu. Rev. Microbiol. 71:579-96
77. Imamovic L, SommerMO. 2013. Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development. Sci. Transl. Med. 5:204ra132
78. Imlay JA. 2009. Oxidative stress. EcoSal Plus 2009. https://doi. org/10. 1128/ecosalplus. 5. 4. 4
79. Ippoliti PJ, Delateur NA, Jones KM, Beuning PJ. 2012. Multiple strategies for translesion synthesis in bacteria. Cells 1:799-831
80. Jara LM, Perez-VarelaM, Corral J, ArchM, Cortes P, et al. 2015. Novobiocin inhibits the antimicrobial resistance acquired through DNA damage-induced mutagenesis in Acinetobacter baumannii. Antimicrob. Agents Chemother. 60:637-39
81. Jee J, Rasouly A, Shamovsky I, Akivis Y, Steinman SR, et al. 2016. Rates and mechanisms of bacterial mutagenesis from maximum-depth sequencing. Nature 534:693-96
82. Jones-Lepp TL. 2006. Chemical markers of human waste contamination: Analysis of urobilin and pharmaceuticals in source waters. J. Environ. Monit. 8:472-78
83. Kamruzzaman M, Shoma S, Thomas CM, Partridge SR, Iredell JR. 2017. Plasmid interference for curing antibiotic resistance plasmids in vivo. PLOS ONE 12:e0172913
84. Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. 2008. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in SouthWales, UK. Water Res. 42:3498-518
85. Kim S, Lieberman TD, Kishony R. 2014. Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. PNAS 111:14494-99
86. KohanskiMA, DePristoMA, Collins JJ. 2010. Sublethal antibiotic treatment leads tomultidrug resistance via radical-induced mutagenesis. Mol. Cell 37:311-20
87. Konola JT, Sargent KE, Gow JB. 2000. Efficient repair of hydrogen peroxide-induced DNA damage by Escherichia coli requires SOS induction of RecA and RuvA proteins. Mutat. Res. 459:187-94
88. Laureti L, Matic I, Gutierrez A. 2013. Bacterial responses and genome instability induced by subinhibitory concentrations of antibiotics. Antibiotics 2:100-14
89. Lee AM, Ross CT, Zeng BB, Singleton SF. 2005. A molecular target for suppression of the evolution of antibiotic resistance: inhibition of the Escherichia coli RecA protein by N6-(1-naphthyl)-ADP. J. Med. Chem. 48:5408-11
90. Lee AM, Singleton SF. 2004. Inhibition of the Escherichia coli RecA protein: zinc(II), copper(II) and mercury(II) trap RecA as inactive aggregates. J. Inorg. Biochem. 98:1981-86
91. Letchumanan V, Chan KG, Lee LH. 2015. An insight of traditional plasmid curing in Vibrio species. Front. Microbiol. 6:735
92. Levin DE, Marnett LJ, Ames BN. 1984. Spontaneous and mutagen-induced deletions: mechanistic studies in Salmonella tester strain TA102. PNAS 81:4457-61
93. LewinCS, Amyes SG. 1991. The role of the SOS response in bacteria exposed to zidovudine or trimethoprim. J. Med. Microbiol. 34:329-32
94. Liu P, Wu Z, Xue H, Zhao X. 2017. Antibiotics trigger initiation of SCCmec transfer by inducing SOS responses. Nucleic Acids Res. 45:3944-52
95. Lobritz MA, Belenky P, Porter CB, Gutierrez A, Yang JH, et al. 2015. Antibiotic efficacy is linked to bacterial cellular respiration. PNAS 112:8173-80
96. Long H, Miller SF, Strauss C, Zhao C, Cheng L, et al. 2016. Antibiotic treatment enhances the genomewide mutation rate of target cells. PNAS 113:E2498-505
97. López E, ElezM, Matic I, Blázquez J. 2007. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli. Mol. Microbiol. 64:83-93
98. Lorian V. 1975. Some effects of subinhibitory concentrations of antibiotics on bacteria. Bull. N. Y. Acad. Med. 51:1046-55
99. Lu TK, Collins JJ. 2009. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. PNAS 106:4629-34
100. Maciá MD, Blanquer D, Togores B, Sauleda J, Pérez JL, Oliver A. 2005. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob. Agents Chemother. 49:3382-86
101. Maiques E, Ubeda C, Campoy S, Salvador N, Lasa I, et al. 2006.-Lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J. Bacteriol. 188:2726-29
102. Mao EF, Lane L, Lee J, Miller JH. 1997. Proliferation of mutators in A cell population. J. Bacteriol. 179:417-22
103. Mathieu A, Fleurier S, Frenoy A, Dairou J, Bredeche MF, et al. 2016. Discovery and function of a general core hormetic stress response in E. coli induced by sublethal concentrations of antibiotics. Cell Rep. 17:46-57
104. McManus PS, Stockwell VO, Sundin GW, Jones AL. 2002. Antibiotic use in plant agriculture. Annu. Rev. Phytopathol. 40:443-65
105. Miller C, Thomsen LE, Gaggero C, Mosseri R, Ingmer H, Cohen SN. 2004. SOS response induction by-lactams and bacterial defense against antibiotic lethality. Science 305:1629-31
106. Miller JH. 1998. Mutators in Escherichia coli. Mutat. Res. 409:99-106
107. Miyazawa M, Hisama M. 2003. Antimutagenic activity of flavonoids from Chrysanthemum morifolium. Biosci. Biotechnol. Biochem. 67:2091-99
108. Miyazawa M, Sakano K, Nakamura S, Kosaka H. 1999. Antimutagenic activity of isoflavones from soybean seeds (Glycine max Merrill). J. Agric. Food Chem. 47:1346-49
109. MiyazawaM, SakanoK, Nakamura S, KosakaH. 2001. Antimutagenic activity of isoflavone from Pueraria lobata. J. Agric. Food Chem. 49:336-41
110. MoCY, CulybaMJ, Selwood T, Kubiak JM, HostetlerZM, et al. 2018. Inhibitors of LexA autoproteolysis and the bacterialSOSresponse discovered by an academic-industry partnership. ACS Infect. Dis. 4:349-59
111. Mo CY, Manning SA, RoggianiM, CulybaMJ, Samuels AN, et al. 2016. Systematically altering bacterial SOS activity under stress reveals therapeutic strategies for potentiating antibiotics. mSphere 1:e00163-16
112. Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G. 2011. Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. Int. J. Med. Microbiol. 301:229-36
113. Nair CG, Chao C, Ryall B, Williams HD. 2012. Sub-lethal concentrations of antibiotics increase mutation frequency in the cystic fibrosis pathogen Pseudomonas aeruginosa. Lett. Appl. Microbiol. 56:149-54
114. Nautiyal A, Patil KN, Muniyappa K. 2014. Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOSresponse:RecA as a potential target for antibacterial drug discovery. J. Antimicrob. Chemother. 69:1834-43
115. Newcombe HB. 1949. Origin of bacterial variants. Nature 164:150
116. NohmiT. 2006. Environmental stress and lesion-bypassDNApolymerases. Annu. Rev. Microbiol. 60:231-53
117. Oethinger M, KernWV, Jellen-Ritter AS, McMurry LM, Levy SB. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13
118. Ojala V, Laitalainen J, Jalasvuori M. 2013. Fight evolution with evolution: plasmid-dependent phages with a wide host range prevent the spread of antibiotic resistance. Evol. Appl. 6:925-32
119. Oliver A, Baquero F, Blázquez J. 2002. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol. Microbiol. 43:1641-50
120. Oliver A, Cantón R, CampoP, Baquero F, Blázquez J. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-54
121. Orlen H, Hughes D. 2006. Weak mutators can drive the evolution of fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 50:3454-56
122. Pal C, Papp B, Lazar V. 2015. Collateral sensitivity of antibiotic-resistant microbes. Trends Microbiol. 23:401-7
123. Peng Q, Zhou S, Yao F, Hou B, Huang Y, et al. 2011. Baicalein suppresses the SOS response system of Staphylococcus aureus induced by ciprofloxacin. Cell Physiol. Biochem. 28:1045-50
124. Pérez-Capilla T, Baquero MR, Gómez-Gómez JM, Ionel A, Martn S, Blázquez J. 2005. SOSindependent induction of dinB transcription by-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J. Bacteriol. 187:1515-18
125. Peterson EJ, Janzen WP, Kireev D, Singleton SF. 2012. High-throughput screening for RecA inhibitors using a transcreener adenosine 5-O-diphosphate assay. Assay Drug Dev. Technol. 10:260-68
126. Phillips I, Culebras E, Moreno F, Baquero F. 1987. Induction of the SOS response by new 4-quinolones. J. Antimicrob. Chemother. 20:631-38
127. Pietta PG. 2000. Flavonoids as antioxidants. J. Nat. Prod. 63:1035-42
128. Pletz MW, Rau M, Bulitta J, De Roux A, Burkhardt O, et al. 2004. Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers. Antimicrob. Agents Chemother. 48:3765-72
129. Pomerantz RT, Goodman MF, O'Donnell ME. 2013. DNA polymerases are error-prone at RecAmediated recombination intermediates. Cell Cycle 12:2558-63
130. Quoc Tuc D, Elodie MG, Pierre L, Fabrice A, Marie-Jeanne T, et al. 2017. Fate of antibiotics from hospital and domestic sources in a sewage network. Sci. Total Environ. 575:758-66
131. Radman M, Taddei F, Matic I. 2000. Evolution-driving genes. Res. Microbiol. 151:91-95
132. Rayssiguier C, Thaler DS, Radman M. 1989. The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature 342:396-401
133. Recacha E, Machuca J, Diaz de Alba P, Ramos-Guelfo M, Docobo-Perez F, et al. 2017. Quinolone resistance reversion by targeting the SOS response. mBio 8:e00971-17
134. Ren L, RahmanMS, HumayunMZ. 1999. Escherichia coli cells exposed to streptomycin display amutator phenotype. J. Bacteriol. 181:1043-44
135. Rodrguez-Beltrán J, Tourret J, Tenaillon O, López E, Bourdelier E, et al. 2015. High recombinant frequency in extraintestinal pathogenic Escherichia coli strains. Mol. Biol. Evol. 32:1708-16
136. Rodrguez-Rojas A, Couce A, Blázquez J. 2010. Frequency of spontaneous resistance to fosfomycin combined with different antibiotics in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 54:4948-49
137. Rodrguez-Rojas A, Makarova O, Rolff J. 2014. Antimicrobials, stress and mutagenesis. PLOS Pathog. 10:e1004445
138. Rosenberg SM. 2001. Evolving responsively: Adaptive mutation. Nat. Rev. Genet. 2:504-15
139. Sangurdekar DP, Zhang Z, Khodursky AB. 2011. The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug trimethoprim. BMC Genom. 12:583
140. SchroderW, Bernhardt J, Marincola G, Klein-Hitpass L, Herbig A, et al. 2014. Altering gene expression by aminocoumarins: The role of DNA supercoiling in Staphylococcus aureus. BMC Genom. 15:291
141. Schroder W, Goerke C, Wolz C. 2013. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus. J. Antimicrob. Chemother. 68:529-38
142. Shaver AC, DombrowskiPG, Sweeney JY, TreisT, ZappalaRM, SniegowskiPD. 2002. Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. Genetics 162:557-66
143. Sheng L, Rasco B, Zhu MJ. 2016. Cinnamon oil inhibits Shiga toxin type 2 phage induction and Shiga toxin type 2 production in Escherichia coli O157:H7. Appl. Environ. Microbiol. 82:6531-40
144. Simmons LA, Foti JJ, Cohen SE, Walker GC. 2008. The SOS regulatory network. EcoSal Plus 2008. https://doi. org/10. 1128/ecosalplus. 5. 4. 3
145. Sioud M, Boudabous A, Cekaite L. 2009. Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs. Int. J. Mol. Med. 23:33-39
146. Smith PA, Romesberg FE. 2007. Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation. Nat. Chem. Biol. 3:549-56
147. Song LY, Goff M, Davidian C, Mao Z, London M, et al. 2016. Mutational consequences of ciprofloxacin in Escherichia coli. Antimicrob. Agents Chemother. 60:6165-72
148. Tanimoto K, Tomita H, Fujimoto S, Okuzumi K, Ike Y. 2008. Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the highpotency drug doripenem inhibits mutant formation. Antimicrob. Agents Chemother. 52:3795-800
149. Thi TD, López E, Rodrguez-Rojas A, Rodrguez-Beltrán J, Couce A, et al. 2011. Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials. J. Antimicrob. Chemother. 66:531-38
150. Torres-Barcelo C, Kojadinovic M, Moxon R, MacLean RC. 2015. The SOS response increases bacterial fitness, but not evolvability, under a sublethal dose of antibiotic. Proc. Biol. Sci. 282:20150885
151. Vaisman A, McDonald JP, Woodgate R. 2012. Translesion DNA synthesis. EcoSal Plus 2012. https://doi. org/10. 1128/ecosalplus. 7. 2. 2
152. Valencia EY, Esposito F, Spira B, Blázquez J, Galhardo RS. 2017. Ciprofloxacin-mediated mutagenesis is suppressed by subinhibitory concentrations of amikacin in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 61:e02107-16
153. VeiglML, Schneiter S, Mollis S, Sedwick WD. 1991. Specificities mediated by neighboring nucleotides appear to underlie mutation induced by antifolates in E. coli. Mutat. Res. 246:75-91
154. Waksman SA. 1947. What is an antibiotic or an antibiotic substance Mycologia 39:565-69
155. Wigle TJ, Lee AM, Singleton SF. 2006. Conformationally selective binding of nucleotide analogues to Escherichia coli RecA: A ligand-based analysis of the RecA ATP binding site. Biochemistry 45:4502-13
156. Wigle TJ, Sexton JZ, Gromova AV, Hadimani MB, Hughes MA, et al. 2009. Inhibitors of RecA activity discovered by high-throughput screening: cell-permeable small molecules attenuate the SOS response in Escherichia coli. J. Biomol. Screen. 14:1092-101
157. Wigle TJ, Singleton SF. 2007. Directed molecular screening for RecA ATPase inhibitors. Bioorg. Med. Chem. Lett. 17:3249-53
158. Witte W. 1998. Medical consequences of antibiotic use in agriculture. Science 279:996-97
159. Yakimov A, Pobegalov G, Bakhlanova I, Khodorkovskii M, Petukhov M, Baitin D. 2017. Blocking the RecA activity and SOS-response in bacteria with a short alpha-helical peptide. Nucleic Acids Res. 45:9788-96
160. Yamada M, Nunoshiba T, Shimizu M, Gruz P, Kamiya H, et al. 2006. Involvement of Y-family DNA polymerases in mutagenesis caused by oxidized nucleotides in Escherichia coli. J. Bacteriol. 188:4992-95
161. Yang Y, Fix D. 2006. Genetic analysis of the anti-mutagenic effect of genistein in Escherichia coli. Mutat. Res. 600:193-206
162. Yim G, McClure J, Surette MG, Davies JE. 2011. Modulation of Salmonella gene expression by subinhibitory concentrations of quinolones. J. Antibiot. 64:73-78
163. Ysern P, Clerch B, Castano M, Gibert I, Barbe J, Llagostera M. 1990. Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. Mutagenesis 5:63-66